Skip to main content
TipRanks
Go Ultimate75% OFF

Century Therapeutics (IPSC) Ownership - Who Owns Century Therapeutics?

297 Followers

Century Therapeutics (IPSC) Ownership Overview

  • 3.27% Insiders
  • 5.61% Mutual Funds
  • 0.07% Other Institutional Investors
  • 7.01% ETFs
  • 84.02% Public Companies and Individual Investors

The ownership structure of Century Therapeutics (IPSC) stock is a mix of institutional, retail, and individual investors. Approximately 12.70% of the company’s stock is owned by Institutional Investors, 3.27% is owned by Insiders, and 84.02% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
Nov 04, 2026Douglas Carr$402
Sep 14, 2026Douglas Carr$3,200
Sep 14, 2026Russotti Gregory$4,993
Sep 08, 2026Russotti Gregory$1,095

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue
Jun 30, 2026 $19,824,832
Jun 30, 2026Woodline Partners Lp$10,430,949

Top Shareholders

IPSC top shareholders
Holder# of SharesType% HoldingValue
Peter Kolchinsky17,754,430Institution9.80%30,892,708
Brad Bolzon12,166,109Institution6.72%21,169,030
BlackRock, Inc.8,091,768Institution4.47%14,079,676
Vanguard6,587,032Institution3.64%11,461,436
Vanguard Index Funds5,562,497Institution3.07%9,678,745
Ishares4,617,034Institution2.55%8,033,639
Michael Rockefeller4,257,530Institution2.35%7,408,102
Brent Pfeiffenberger3,633,839Insider2.01%6,322,880
Fidelity Salem Street Trust1,515,532Institution0.84%2,637,026
Chad Cowan1,186,019Insider0.65%2,063,673

Top Mutual Fund Holders

IPSC top mutual fund holders
Holder# of SharesType% HoldingValue
Vanguard Index Funds5,562,497Institution3.07%9,678,745
Fidelity Salem Street Trust1,515,532Institution0.84%2,637,026
Fidelity Concord Street Trust974,875Institution0.54%1,696,283
Vanguard Scottsdale Funds832,121Institution0.46%1,447,891
Schwab Capital Trust378,867Institution0.21%659,229
Tiaa-cref Funds221,849Institution0.12%386,017
Vanguard World Fund191,946Institution0.11%333,986
Vanguard Valley Forge Funds76,004Institution0.04%132,247
Vanguard Institutional Index Funds65,179Institution0.04%113,411
Valic Co I53,871Institution0.03%93,736

Top ETF Holders

IPSC top ETF holders
Holder# of SharesType% HoldingValue
Vanguard Total Stock Market ETF, VTI ETF4,339,806Institution2.40%7,421,068
iShares Russell 2000 ETF, IWM ETF3,016,782Institution1.67%5,249,201
Vanguard Extended Market ETF, VXF ETF1,211,598Institution0.67%2,071,833
iShares Russell 2000 Value ETF, IWN ETF1,183,085Institution0.65%2,058,568
Vanguard Russell 2000 ETF, VTWO ETF719,243Institution0.40%1,229,906
iShares Micro-Cap ETF, IWC ETF369,996Institution0.20%643,793
Invesco Russell 2000 Dynamic Multifactor ETF, OMFS ETF223,581Institution0.12%389,031
Avantis U.S Small Cap Equity ETF, AVSC ETF219,301Institution0.12%368,426
Vanguard Health Care ETF, VHT ETF192,156Institution0.11%328,587
Fidelity Enhanced Small Cap ETF, FESM ETF191,306Institution0.11%321,394

FAQ

Who Owns Century Therapeutics (IPSC)?
According to the latest TipRanks data, approximately 12.70% of the company's stock is held by institutional investors, 3.27% is held by insiders, and 84.02% is held by public companies and individual investors.
What percentage of Century Therapeutics (IPSC) stock is held by institutional investors?
According to the latest TipRanks data, approximately 12.70% of Century Therapeutics (IPSC) stock is held by institutional investors: 5.61% by mutual funds, 7.01% by ETFs and 0.07% by other institutional investors.
What percentage of Century Therapeutics (IPSC) stock is held by retail investors?
According to the latest TipRanks data, approximately 84.02% of Century Therapeutics (IPSC) stock is held by public companies and individual investors.
Who owns the most shares of Century Therapeutics (IPSC)?
Peter Kolchinsky owns the most shares of Century Therapeutics (IPSC).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.